| ETHYL 5-NITROBENZOFURAN-2-CARBOXYLATE |
69604-00-8 |
C11H9NO5 |
| ethyl 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxylate (dihydrochloride) |
163521-09-3 |
C28H30N4O3.HCl |
| VILAZODONE |
163521-12-8 |
C26H27N5O2 |
| 2-Chloromethyl-3-methyl-4-(3-methoxypropoxy)pyridine hydrochloride |
153259-31-5 |
C11H16NO2Cl.HCl |
| Rabeprazole |
117976-89-3 |
C18H21N3O3S |
| Rebeprazole sodium |
117976-90-6 |
C18H20N3O3S-.Na+ |
| Frovatriptan succinate |
158930-09-7 |
C14H17N3O.C4H6O4 |
| 5-Azacytidine |
320-67-2 |
C8H12N4O5 |
| 2,3,4,5-Tetrahydro-5-methyl-1H-pyrido[4,3-b]indol-1-one |
122852-75-9 |
C12H12N2O |
| 5-Nitrosalicylaldehyde |
97-51-8 |
C7H5NO4 |
| (3aR,12bR)-rel-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one |
912356-08-2 |
C17H14NO2Cl |
| 5-Chloro-2-methyl-2,3-dihydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole-(2H)-one |
934996-79-9 |
C17H12NO2Cl |
| trans-(+/-)-11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one |
129385-59-7 |
C17H14NO2Cl |
| 11-Chloro-2,3-dihydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one |
1012884-46-6 |
C17H12NO2Cl |
| trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole maleate |
85650-56-2 |
C17H16NOCl.C4H4O4 |
| 2(1H)-pyridine,3-chloro-5,6-dihydro-1-(4-nitrophenyl) |
536760-29-9 |
C11H9N2O3Cl |
| 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester |
536759-91-8 |
C22H20N4O6 |
| 1-(4-Methoxyphenyl)-6-(4-iodophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl este |
473927-64-9 |
C22H20N3O4I |
| 16a(R),17-(Butylidenebis(oxy))-11b,21-dihydroxypregna-1,4-diene-3,20-dione |
51372-29-3 |
C25H34O6 |
| Budesonide |
51333-22-3 |
C25H34O6 |
